Informational Webinar for NINDS PAR-16-112 "Biomarkers Discovery in Parkinsonism (U01)"

Notice Number: NOT-NS-17-036

Key Dates
Release Date:  July 21, 2017

Related Announcements

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)


The National Institute for Neurological Disorders and Stroke (NINDS) will be holding an informational webinar on July 31, 2017 from 12-1:30 pm EST for the Funding Opportunity Announcement (FOA) PAR-16-112, entitled "Biomarkers Discovery in Parkinsonism (U01)".

The webinar will provide a brief introduction to the FOA and current resources available through the NINDS Parkinson's disease Biomarkers Program (PDBP).  Clinical or laboratory based biomarker discovery projects supported under this FOA include research directed towards the identification and/or replication of: 1) diagnostic, prognostic and progression biomarkers that differentiate synucleinopathies from tauopathies; or 2) diagnostic, prognostic and progression biomarkers for sub-types of Parkinson's disease (PD) including genetically defined cohorts, biologically defined cohorts of idiopathic PD and ethnic subgroups of idiopathic PD.  The inclusion of cutting edge approaches such as telemedicine or mobile technology monitoring are encouraged.

To join the WebEx meeting the following link and telephone information are provided:   |  622 274 563    
Join by phone 
1-650-479-3208 Call-in toll number (US/Canada) 
1-877-668-4493 Call-in toll-free number (US/Canada) 
Access code: 622 274 563 
Global call-in numbers  |  Toll-free calling restrictions

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application.


Please direct all inquiries to:

Margaret Sutherland, PhD
National Institute for Neurological Disorders and Stroke
Telephone: 301-496-5680